Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
Bicara Therapeutics updates registry record NCT07807163: recruitingSep 8Trial updateBicara Therapeuticsficerafusp alfaRecord notice
Bicara names successor CEO, reports pivotal trial on track for 2027 readoutAug 11Quarterly updateBicara Therapeutics